Rezolute (RZLT) Return on Capital Employed Growth (3y) (2016 - 2026)

Rezolute (RZLT) Return on Capital Employed Growth (3y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (3y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn - -
3 Akari Therapeutics 1,045.06 Bn 1,045.06 Bn - -
4 BeOne Medicines 470.64 Bn 465.84 Bn 1.35 Bn 4,893.00
5 Vertex Pharmaceuticals 122.91 Bn 115.67 Bn 2.59 Bn -494.00
6 Regeneron Pharmaceuticals 70.07 Bn 61.31 Bn 3.31 Bn -649.00
7 Belite Bio 62.77 Bn 62.77 Bn - -
8 Argenx Se 56.21 Bn 51.02 Bn 1.41 Bn -
9 Revolution Medicines 37.60 Bn 37.60 Bn - -3,782.00
10 Rezolute 508.76 Mn 508.76 Mn - -3,168.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,168.00
Dec 31, 2025 -3,284.00
Sep 30, 2025 -2,350.00
Jun 30, 2025 -2,630.00
Mar 31, 2025 -3,254.00
Dec 31, 2024 -1,012.00
Sep 30, 2024 1,116.00
Jun 30, 2024 -604.00
Mar 31, 2024 -869.00
Dec 31, 2023 3,223.00
Sep 30, 2023 24,729.00
Jun 30, 2023 16,836.00
Mar 31, 2023 10,441.00
Dec 31, 2022 14,639.00
Sep 30, 2022 17,638.00
Jun 30, 2022 43,495.00
Mar 31, 2022 249,931.00
Dec 31, 2021 -105,162.00
Sep 30, 2021 -51,328.00
Jun 30, 2021 -124,844.00